Overview

An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery

Status:
Withdrawn
Trial end date:
2017-07-27
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study will be to evaluate a standardized, evidence-based protocol versus a conventional approach for the dosing of oxytocin in vaginal delivery.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Treatments:
Oxytocin
Criteria
Inclusion Criteria:

- Vaginal Delivery

Exclusion Criteria:

- Cesarean Delivery

- Allergy to Oxytocin

- Cardiac Arrhythmia